| Original language | English |
|---|---|
| Pages (from-to) | 228A-228A |
| Number of pages | 1 |
| Journal | Blood |
| Volume | 100 |
| Issue number | 11 |
| State | Published - Nov 16 2002 |
Fixed dosing (200 meg Q2W) of darbepoetin alfa appears to be as effective as weight-based dosing (3 meg/kg Q2W) in chemotherapy-induced anemia: Results of a clinical trial simulation.
N Jumbe, Y Bin, R Rovetti, A Heatherington
Research output: Contribution to journal › Meeting abstract › peer-review